By Elizabeth Lucas September 12, 2019
Elizabeth Lucas, Kaiser Health News
Members of Congress raked in nearly $four million from pharmaceutical producers and their commerce teams within the first six months of 2019. Two members — Sen. Chris Coons (D-Del.) and Sen. Thom Tillis (R-N.C.) — every acquired over $100,000. Rep. Greg Walden (R-Ore.) is $5,000 shy of qualifying for the “million-dollar club,” a gaggle of present members who’ve acquired $1 million or extra since 2007.
The pharmaceutical business has a protracted historical past of looking for to affect laws by donating to the committees managed by highly effective members of Congress. As they return from recess and drug-pricing laws comes into focus, learn how a lot your state’s representatives and senators took from the business by inspecting KHN’s unique “Pharma Cash to Congress” characteristic.
We encourage organizations to republish our content material, freed from cost. Here’s what we ask:
You should credit score us as the unique writer, with a hyperlink to our khn.org web site. If attainable, please embody the unique creator(s) and “Kaiser Health News” within the byline. Please protect the hyperlinks within the story.
It’s necessary to notice, not every thing on khn.org is obtainable for republishing. If a narrative is labeled “All Rights Reserved,” we can not grant permission to republish that merchandise.
Have questions? Let us know at KHNHelp@kff.org”>KHNHelp@kff.org